Carson Wealth (CWM LLC)
DAWN

Carson Wealth (CWM LLC)’s Day One Biopharmaceuticals DAWN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$537K Buy
25,043
+16,670
+199% +$235K ﹤0.01% 1963
2025
Q4 		$78K Buy
8,373
+2,051
+32% +$17.1K ﹤0.01% 3259
2025
Q3 		$45K Sell
6,322
-11,846
-65% -$81.5K ﹤0.01% 3614
2025
Q2 		$118K Sell
18,168
-3,600
-17% -$24.8K ﹤0.01% 2576
2025
Q1 		$173K Buy
21,768
+21,639
+16,774% +$233K ﹤0.01% 2027
2024
Q4 		$2K Sell
129
-142
-52% -$1.98K ﹤0.01% 4521
2024
Q3 		$4K Buy
271
+200
+282% +$2.85K ﹤0.01% 4168
2024
Q2 		$1K Buy
+71
New +$1.04K ﹤0.01% 4351
2023
Q4 		– Sell
-3
Closed – – 4200
2023
Q3 		$0 Hold
3
– – ﹤0.01% 4236
2023
Q2 		$0 Hold
3
– – ﹤0.01% 4218
2023
Q1 		$0 Hold
3
– – ﹤0.01% 4100
2022
Q4 		$0 Hold
3
– – ﹤0.01% 4012
2022
Q3 		$0 Hold
3
– – ﹤0.01% 3957
2022
Q2 		$0 Buy
+3
New +$31 ﹤0.01% 3843

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Carson Wealth (CWM LLC)'s DAWN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Day One Biopharmaceuticals (DAWN) stake by 199% in Q1 2026, buying an estimated $235K and bringing the position to 25,043 shares worth $537K. The position accounts for ﹤0.01% of the portfolio, ranked #1963.

Carson Wealth (CWM LLC) first reported a position in DAWN in Q2 2022 and has held it in 14 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Carson Wealth (CWM LLC) held 25,043 shares of Day One Biopharmaceuticals worth $537K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 16,670 Day One Biopharmaceuticals shares in Q1 2026, an estimated $235K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1963 holding.
  • Carson Wealth (CWM LLC) first reported a position in Day One Biopharmaceuticals in Q2 2022 and has held it in 14 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.